<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxins (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Toxins (Basel)</journal-id><journal-id journal-id-type="publisher-id">toxins</journal-id><journal-title-group><journal-title>Toxins</journal-title></journal-title-group><issn pub-type="epub">2072-6651</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998109</article-id><article-id pub-id-type="pmc">PMC11861105</article-id>
<article-id pub-id-type="doi">10.3390/toxins17020092</article-id><article-id pub-id-type="publisher-id">toxins-17-00092</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Deciphering the Neurotoxic Effects of <italic toggle="yes">Karenia selliformis</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3810-4695</contrib-id><name><surname>Aballay-Gonz&#x000e1;lez</surname><given-names>Ambbar</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxins-17-00092" ref-type="aff">1</xref><xref rid="af2-toxins-17-00092" ref-type="aff">2</xref><xref rid="fn1-toxins-17-00092" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5501-6582</contrib-id><name><surname>Panes-Fern&#x000e1;ndez</surname><given-names>Jessica</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af3-toxins-17-00092" ref-type="aff">3</xref><xref rid="fn1-toxins-17-00092" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Alves-de-Souza</surname><given-names>Catharina</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxins-17-00092" ref-type="aff">1</xref><xref rid="af2-toxins-17-00092" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Krock</surname><given-names>Bernd</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af2-toxins-17-00092" ref-type="aff">2</xref><xref rid="af4-toxins-17-00092" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2953-7699</contrib-id><name><surname>Gallardo-Rodr&#x000ed;guez</surname><given-names>Juan Jos&#x000e9;</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af5-toxins-17-00092" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Espinoza-Rubilar</surname><given-names>Nicole</given-names></name><xref rid="af3-toxins-17-00092" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Fuentealba</surname><given-names>Jorge</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af3-toxins-17-00092" ref-type="aff">3</xref><xref rid="af6-toxins-17-00092" ref-type="aff">6</xref><xref rid="c1-toxins-17-00092" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Astuya-Villal&#x000f3;n</surname><given-names>Allisson</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-toxins-17-00092" ref-type="aff">1</xref><xref rid="af2-toxins-17-00092" ref-type="aff">2</xref><xref rid="c1-toxins-17-00092" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-toxins-17-00092"><label>1</label>Laboratorio de Biotoxinas, Departamento de Oceanograf&#x000ed;a, Facultad de Ciencias Naturales y Oceanogr&#x000e1;ficas, Universidad de Concepci&#x000f3;n, Concepci&#x000f3;n 4070409, Chile; <email>amaballay@udec.cl</email> (A.A.-G.); <email>cathalves@udec.cl</email> (C.A.-d.-S.)</aff><aff id="af2-toxins-17-00092"><label>2</label>Centro de Investigaci&#x000f3;n Oceanogr&#x000e1;fica COPAS COASTAL, Universidad de Concepci&#x000f3;n, Concepci&#x000f3;n 4070409, Chile; <email>bernd.krock@awi.de</email></aff><aff id="af3-toxins-17-00092"><label>3</label>Laboratorio de Screening de Compuestos Neuroactivos, Departamento de Fisiolog&#x000ed;a, Facultad de Ciencias Biol&#x000f3;gicas, Universidad de Concepci&#x000f3;n, Concepci&#x000f3;n 4070409, Chile; <email>jpanes@udec.cl</email> (J.P.-F.); <email>nicespinoza@udec.cl</email> (N.E.-R.)</aff><aff id="af4-toxins-17-00092"><label>4</label>Alfred-Wegener-Institut Helmholtz-Zentrum f&#x000fc;r Polar-und Meeresforschung, Am Handelshafen 12, D-27570 Bremerhaven, Germany</aff><aff id="af5-toxins-17-00092"><label>5</label>Department of Chemical Engineering, Research Centre CIAIMBITAL, University of Almer&#x000ed;a, 04120 Almer&#x000ed;a, Spain; <email>jgr285@ual.es</email></aff><aff id="af6-toxins-17-00092"><label>6</label>Centro de Investigaciones Avanzadas en Biomedicina (CIAB-UdeC), Facultad de Ciencias Biol&#x000f3;gicas, Universidad de Concepci&#x000f3;n, Concepci&#x000f3;n 4070409, Chile</aff><author-notes><corresp id="c1-toxins-17-00092"><label>*</label>Correspondence: <email>jorgefuentealba@udec.cl</email> (J.F.); <email>aastuya@udec.cl</email> (A.A.-V.)</corresp><fn id="fn1-toxins-17-00092"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>15</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>2</issue><elocation-id>92</elocation-id><history><date date-type="received"><day>07</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>11</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>12</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic toggle="yes">Karenia selliformis</italic> is a globally recognized dinoflagellate associated with harmful algal blooms and massive fish kills along southern Chilean coasts. Its toxicity varies with environmental factors and genetic diversity. While <italic toggle="yes">K. selliformis</italic> is traditionally linked to neurotoxins like gymnodimines (GYMs), analysis of the strain CREAN-KS02 from Chile&#x02019;s Ays&#x000e9;n Region (43&#x000b0; S) revealed no presence of toxins associated with this genus, such as gymnodimines, brevetoxins, or brevenal. Given the high toxicity and impact on marine life, our study aimed to functionally characterize the neurotoxic metabolites in the exudate of <italic toggle="yes">K. selliformis</italic> cultures. Cytotoxicity was evaluated using a Neuro-2a cell-based assay (CBA), determining an IC<sub>50</sub> of 2.41 &#x000b1; 0.02 &#x003bc;g mL<sup>&#x02212;1</sup>. The incubation of Neuro-2a cells with the bioactive lipophilic extract obtained from the exudate of <italic toggle="yes">K. selliformis</italic> and the ouabain/veratridine couple showed activation of voltage-gated ion channels. Electrophysiological recordings on cultured mouse hippocampal neurons showed that the extract increased cell excitability in a dose-dependent manner, modulating action potential firing and exhibiting an opposed effect to tetrodotoxin. These findings indicate the presence of excitatory neurotoxic compounds affecting mammalian cells. This study provides the first mechanistic evidence of <italic toggle="yes">K. selliformis</italic> toxicity and highlights potential risks associated with its proliferation in marine environments.</p></abstract><kwd-group><kwd>dinoflagellate</kwd><kwd>harmful algal blooms</kwd><kwd>neurotoxic compounds</kwd></kwd-group><funding-group><award-group><funding-source>Fondecyt</funding-source><award-id>1200845</award-id><award-id>1200908</award-id></award-group><award-group><funding-source>COPAS-COASTAL ANID</funding-source><award-id>FB210021</award-id></award-group><award-group><funding-source>Agencia Nacional de Investigaci&#x000f3;n y Desarrollo (ANID)</funding-source><funding-source>Subdirecci&#x000f3;n de Capital Humano</funding-source><award-id>21211641</award-id></award-group><funding-statement>This research was funded by the project Fondecyt 1200845 (AAV), Fondecyt 1200908 (JF) (ANID), COPAS-COASTAL ANID FB210021 and Agencia Nacional de Investigaci&#x000f3;n y Desarrollo (ANID), Subdirecci&#x000f3;n de Capital Humano, beca doctorado nacional 21211641.</funding-statement></funding-group></article-meta><notes notes-type="Key Contribution"><title>Key Contribution</title><p>The bioactive lipophilic extract derived from the exudate of the Chilean <italic toggle="yes">Karenia selliformis</italic> strain (CREAN-KS02) (ExKs) exhibits excitatory neurotoxic activity, affecting Neuro-2a neuroblastoma cells and mouse hippocampal neurons.</p></notes></front><body><sec sec-type="intro" id="sec1-toxins-17-00092"><title>1. Introduction</title><p>Fish-killing microalgal blooms have emerged as widespread global threats. These events have greater socio-economic impacts than the more extensively studied harmful algal blooms, which may cause seafood biotoxin contamination. <italic toggle="yes">Karenia selliformis</italic> is a dinoflagellate known worldwide for its association with ichthyotoxic harmful algal blooms. It has been responsible for massive fishkill events in southern Chile [<xref rid="B1-toxins-17-00092" ref-type="bibr">1</xref>]. Regarding ichthyotoxins (i.e., bioactive compounds produced by microalgae that kill fish), the most common mechanism of killing fish is by damaging the sensitive gill membranes of fish (e.g., by karlotoxin, karmitoxin, prymnesins) [<xref rid="B2-toxins-17-00092" ref-type="bibr">2</xref>]. However, additional evidence demonstrated that both direct and indirect exposure to <italic toggle="yes">K. selliformis</italic> induces pathological damage to the intestine and liver tissues of medaka fish, with varying degrees of severity [<xref rid="B3-toxins-17-00092" ref-type="bibr">3</xref>].</p><p>It is well known that several species of <italic toggle="yes">Karenia</italic> produce neurotoxins. This species was primarily associated with the production of neurotoxins known as gymnodimines (GYMs) [<xref rid="B4-toxins-17-00092" ref-type="bibr">4</xref>,<xref rid="B5-toxins-17-00092" ref-type="bibr">5</xref>], characterized for targeting muscular and neuronal nicotinic acetylcholine receptors [<xref rid="B6-toxins-17-00092" ref-type="bibr">6</xref>,<xref rid="B7-toxins-17-00092" ref-type="bibr">7</xref>,<xref rid="B8-toxins-17-00092" ref-type="bibr">8</xref>]. The analytical characterization of Chilean <italic toggle="yes">K. selliformis</italic> strains revealed the absence of gymnodimines as well as compounds such as brevetoxins and brevenal reported in other <italic toggle="yes">Karenia</italic> species [<xref rid="B1-toxins-17-00092" ref-type="bibr">1</xref>]. Nevertheless, laboratory bioassays have shown the extreme toxicity of a Chilean <italic toggle="yes">K. selliformis</italic> strain on rainbow trout gill (RTgill-W1) cell line [<xref rid="B9-toxins-17-00092" ref-type="bibr">9</xref>] as well as its allelopathic effect on other microalgae [<xref rid="B10-toxins-17-00092" ref-type="bibr">10</xref>], suggesting the presence of uncharacterized toxins.</p><p>Despite the relevance of <italic toggle="yes">K. selliformis</italic> to aquaculture activities in Chile, due to the high mortality rates associated with their blooms in Patagonian fjords, little is still known about the toxic metabolites produced by this species and their cellular mechanisms of toxicity. Reports suggest that toxins produced by <italic toggle="yes">K. selliformis</italic> can be transferred through the food chain [<xref rid="B3-toxins-17-00092" ref-type="bibr">3</xref>,<xref rid="B11-toxins-17-00092" ref-type="bibr">11</xref>]. Therefore, it is crucial to elucidate the cellular effects of the toxins present in the crude exudates of Chilean <italic toggle="yes">K. selliformis</italic> strains to better understand the negative effects on aquaculture.</p><p>The Chilean <italic toggle="yes">K. selliformis</italic> CREAN_KS02 strain did not produce any known variants of gymnodimines or brevetoxins [<xref rid="B1-toxins-17-00092" ref-type="bibr">1</xref>]. However, its extracts contained two compounds with the same mass transition as brevenal, a compound related to brevetoxins. Two peaks in the ion trace corresponding to brevenal&#x02019;s mass transition (<italic toggle="yes">m/z</italic> 657.4 &#x0003e; 639.4) appeared at 3.39 and 3.61 min. This observation led to the collection of collision-induced dissociation (CID) spectra for these compounds. The CID spectra clearly demonstrated that neither compound matched brevenal, as their fragmentation patterns differed distinctly from brevenal&#x02019;s spectrum (Figure 5 of [<xref rid="B1-toxins-17-00092" ref-type="bibr">1</xref>]). These findings suggest the presence of previously unknown toxins. As many marine neurotoxins have been described to bind ion channels, specifically voltage-gated sodium channels (VGSCs) [<xref rid="B12-toxins-17-00092" ref-type="bibr">12</xref>,<xref rid="B13-toxins-17-00092" ref-type="bibr">13</xref>], we expect to observe modulation of receptors or channels due to the presence of potential neurotoxic compounds. If confirmed, this will represent a crucial step toward understanding their cytotoxic and neurotoxic effects and achieving their mechanistic characterization. This study aims to enhance the knowledge of the cellular and molecular effects of bioactive compounds present in the exudate of the <italic toggle="yes">K. selliformis</italic> strain CREAN-KS02, isolated from the Ays&#x000e9;n Region, and to functionally characterize its neurotoxic metabolites.</p></sec><sec sec-type="results" id="sec2-toxins-17-00092"><title>2. Results</title><sec id="sec2dot1-toxins-17-00092"><title>2.1. Effects of ExKs on Neuro-2a Cell-Based Assay (CBA)</title><p>Using Neuro-2a cells, we tested the toxicity of bioactive lipophilic extract obtained from the exudate of <italic toggle="yes">K. selliformis</italic> cultures (ExKs) in a wide range of concentrations, observing that concentrations equal to or below 2 &#x000b5;g mL<sup>&#x02212;1</sup> of ExKs in culture medium, did not affect cell viability after treatments of 24 h (<xref rid="toxins-17-00092-f001" ref-type="fig">Figure 1</xref>). However, concentrations higher than 2 &#x000b5;g mL<sup>&#x02212;1</sup> showed a clear effect on viability with a drastic reduction in viability. At 2.5 &#x000b5;g mL<sup>&#x02212;1</sup> and 5 &#x000b5;g mL<sup>&#x02212;1</sup>, viability values were 30 and 0.3%, respectively (<xref rid="toxins-17-00092-f001" ref-type="fig">Figure 1</xref>). The IC<sub>50</sub> of ExKs, calculated after 24 h of exposure, was 2.41 &#x000b1; 0.02 &#x000b5;g mL<sup>&#x02212;1</sup>. The control extract, obtained from the culture medium without <italic toggle="yes">Karenia</italic> cells, exhibits cell viability above 90% across most of the concentration range used in this study (<xref rid="toxins-17-00092-f001" ref-type="fig">Figure 1</xref>). However, at 5 &#x000b5;g mL<sup>&#x02212;1</sup>, it reduced viability to 70%. This may be associated with the effect of lipophilic compounds dissolved in seawater from the culture medium.</p><p>The next step was to evaluate the effect of different ExKs concentrations on the cell viability of Neuro-2a cells incubated with ExKs in the presence of ouabain and veratridine. For that, Neuro-2a cells were treated with the Na<sup>+</sup>/K<sup>+</sup>-ATPase inhibitor ouabain (300 &#x000b5;M) and the sodium channel activator veratridine (30 &#x000b5;M M). The reduction in cytotoxicity in the presence of ouabain/veratridine or &#x02018;cell rescue&#x02019; is indicative of a sodium-channel-blocking toxin (paralyzing toxins). Additionally, the enhancement of cytotoxicity in the presence of ouabain (150 &#x000b5;M) and veratridine (15 &#x000b5;M) is indicative of a potent sodium channel activator (brevetoxin-like toxins) [<xref rid="B14-toxins-17-00092" ref-type="bibr">14</xref>,<xref rid="B15-toxins-17-00092" ref-type="bibr">15</xref>]. An experiment was also carried out using saxitoxin (100 nM), incubated with the ExKs and ouabain and veratridine (150 &#x000b5;M/15 &#x000b5;M). The incubation of Neuro-2a cells with ExKs in the presence of 300 &#x000b5;M ouabain and 30 &#x000b5;M veratridine did not exhibit an effect (cell rescue) associated with blocking toxins (<xref rid="app1-toxins-17-00092" ref-type="app">Supplementary Material S1</xref>). The presence of 150 &#x000b5;M ouabain and 15 &#x000b5;M veratridine potentiated over three times the cytotoxic effect of the ExKs extract (<xref rid="toxins-17-00092-f002" ref-type="fig">Figure 2</xref>, blue dots) with an IC<sub>50</sub> at 0.71 &#x000b5;g mL<sup>&#x02212;1</sup>. The black dot in <xref rid="toxins-17-00092-f001" ref-type="fig">Figure 1</xref> shows that, especially at ExKs concentrations in the range of 0.3 to 2 &#x000b5;g mL<sup>&#x02212;1</sup>, the cell viability was above 90% when ExKs was in the absence of ouabain and veratridine. In the presence of ouabain (150 &#x000b5;M) and veratridine (15 &#x000b5;M), proportional cell viability reduction was shown with increasing ExKs concentrations, reaching 2.8% at 1.25 &#x000b5;g mL<sup>&#x02212;1</sup> ExKs. These potentiation effects were dose-dependent, until 1.25 &#x000b5;g mL<sup>&#x02212;1</sup>. Concentrations over this value decreased cell viability at all conditions. Upon co-incubation with 100 nM saxitoxin (<xref rid="toxins-17-00092-f002" ref-type="fig">Figure 2</xref>, black dots) and ExKs concentrations, the IC<sub>50</sub> was 0.83 &#x000b5;g mL<sup>&#x02212;1</sup>. At concentrations equal to or below 0.6 &#x000b5;g mL<sup>&#x02212;1</sup>, the cytotoxic effect was reversed. However, at ExKs concentrations between 1.25 &#x000b5;g mL<sup>&#x02212;1</sup> and 2 &#x000b5;g mL<sup>&#x02212;1</sup>, where ouabain- and veratridine-potentiated cytotoxicity exceeded 90%, no reversion of the cytotoxic effect by saxitoxin was observed.</p></sec><sec id="sec2dot2-toxins-17-00092"><title>2.2. Effect of ExKs on Synaptic Function and Excitability</title><p>To further investigate the effects of ExKs on neuronal synaptic function, a long-term culture of mice hippocampal cells (14 DIV) was electrophysiologically characterized under acute ExKs (1 &#x000b5;g mL<sup>&#x02212;1</sup>) applications, and additionally, we evaluated the treatments using a perfusion chamber with sequential applications of different concentrations of extract (0.01&#x02013;10 &#x000b5;g mL<sup>&#x02212;1</sup>). Throughout the culture period, neurons showed a remarkable ability to reestablish neurites and synaptic connections, developing advanced electrophysiological properties. We applied ExKs to hippocampus neurons in an acute treatment. A TTX positive control (50 mM), serving as a voltage-gated sodium channel inhibitor, was also included. Spontaneous post-synaptic currents (sPSCs) using hole cells in the voltage-clamp configuration were used to register the currents under control conditions and acute exposition to ExKs (<xref rid="toxins-17-00092-f003" ref-type="fig">Figure 3</xref>A). Neurons treated with ExKs demonstrated a significative increase in global synaptic activity, and interestingly, the addition of TTX (&#x000b5;M) induced silencing of the synaptic activity observed in control conditions or after ExKs application. The amplitude of synaptic events in ExKs-treated neurons increased the amplitude of basal currents two-fold (C: 100 &#x000b1; 9%; Ks 208 &#x000b1; 8%).</p><p>Regarding this significative effect on synaptic currents, we evaluated neuronal excitability, the capacity to fire the action potential (APs) and miniature postsynaptic excitatory activities (mEPSC). Analysis of action potentials (APs) using current clamp mode showed that the ExKs perfusion induced a persistent increase in the number of neurons with larger AP-amplitudes after progressive pulse amplitude, subsequently blocked by tetrodotoxin (TTX) pulse (<xref rid="toxins-17-00092-f004" ref-type="fig">Figure 4</xref>A). Notably, APs firing and the percentage of active cells appear to increase after acute ExKs perfusion, reflecting a potentially more sensitive condition of the neurons to develop APs and suggesting the possibility of neurotoxicity in the presence of ExKs. The comparison of properties for individual APs recorded suggests that the excitability was higher for ExKs-treated neurons for randomly sampled neurons (<xref rid="toxins-17-00092-f004" ref-type="fig">Figure 4</xref>A, Control: 100 &#x000b1; 15%; ExKs: 163 &#x000b1; 9%). This comprehensive analysis provides insight into this excitatory property of the ExKs to induce, in this way, damage to central synapses, providing the first evidence and valuable information for potential mechanisms.</p><p>In light of synaptic activity dynamics (specifically modulations in excitatory tone induced by ExKs), we meticulously employed TTX (50 nM) and bicuculline (5 &#x003bc;M) to selectively isolate miniature excitatory postsynaptic currents (mEPSC) in vitro, as illustrated in <xref rid="toxins-17-00092-f004" ref-type="fig">Figure 4</xref>B. The recorded traces demonstrate a significant increase in the frequency of excitatory synaptic currents subsequent to ExKs treatments (Control: 100 &#x000b1; 9%; ExKs: 183 &#x000b1; 18%).</p></sec><sec id="sec2dot3-toxins-17-00092"><title>2.3. ExKs Regulates Neurotransmitter Release via Ca<sup>2+</sup> Handling</title><p>Considering these findings, we sought to assess the connection between neurotoxicity and alterations in cytosolic Ca<sup>2+</sup> levels in hippocampus neurons (<xref rid="toxins-17-00092-f005" ref-type="fig">Figure 5</xref>). To do this, FLUO-4TM-loaded neurons were acutely exposed to ExKs in the same previous conditions (<xref rid="toxins-17-00092-f005" ref-type="fig">Figure 5</xref>A). A pulse of high K<sup>+</sup> solution (KCl, 90 mM) was used as depolarizing control, to check the standard neuron response; after that, the Ca<sup>2+</sup> response to the application of ExKs was evaluated. The exposed neurons showed a strong, rapid and progressive increase in Ca<sup>2+</sup> levels, significative higher than that observed with the KCl control (<xref rid="toxins-17-00092-f005" ref-type="fig">Figure 5</xref>B). This finding corroborates the potent effect of ExKs on neuronal excitability and cell activation, and eliciting Ca<sup>2</sup>&#x0207a; increased those observed under control conditions over two-fold (depolarizing pulse).</p><p>The heightened excitability observed in the presence of the ExKs suggests a potential impact on neuronal and cellular signaling pathways. The disruption of Ca<sup>2+</sup> homeostasis further implies a disturbance in the delicate balance essential for presynapses, since the function of exocytotic machinery is Ca<sup>2+</sup>-dependent. To test this hypothesis, we employed confocal imaging to assess the effects of ExKs on SV2 (Synaptic Vesicle Glycoprotein 2), a key regulator of vesicle trafficking and neurotransmitter release (<xref rid="toxins-17-00092-f006" ref-type="fig">Figure 6</xref>A). Our observations revealed that ExKs led to a strong reduction in the immunoreactivity of SV2, reflexed by a significative decrease in the number of puncta in the primary processes of these neurons (<xref rid="toxins-17-00092-f006" ref-type="fig">Figure 6</xref>B, Control: 100 &#x000b1; 9%; ExKs.: 44 &#x000b1; 6%), suggesting that the excitotoxic effects could induce depletion of presynaptic terminals.</p></sec></sec><sec sec-type="discussion" id="sec3-toxins-17-00092"><title>3. Discussion</title><p>In the present study, we performed a functional characterization of compounds that were extracted from the exudate of a culture of <italic toggle="yes">Karenia selliformis</italic> (ExKs) and conducted a pharmacological comparison with the effects observed with tetrodotoxin (TTX) and saxitoxin (STX) using in vitro neuronal models. Yet uncharacterized compounds of <italic toggle="yes">K. selliformis</italic> CREAN_KS02 demonstrated high cytotoxicity in vitro assays on the rainbow trout gill (RTgill-W1) cell line, suggesting a significant potential for fish mortality and other marine species [<xref rid="B1-toxins-17-00092" ref-type="bibr">1</xref>,<xref rid="B16-toxins-17-00092" ref-type="bibr">16</xref>]. Notably, our results suggest that the ExKs extract induces a series of cellular responses with significant alterations in neurophysiological processes.</p><p>In our evaluation of the cytotoxic effects in the Neuro2A mammalian neuronal lineage model, we found that ExKs exhibits cytotoxicity in the murine model, with an IC<sub>50</sub> of 2.41 &#x000b1; 0.02 &#x000b5;g mL<sup>&#x02212;1</sup>. Approximately the double concentration led to 100% lethality. This rapid neurotoxic effect is described as &#x0201c;on-off&#x0201d; or &#x0201c;fast-acting&#x0201d;, similar to spirolides and gymnodimines [<xref rid="B17-toxins-17-00092" ref-type="bibr">17</xref>]. These results are consistent with those described by other authors regarding fish gill cell lines [<xref rid="B1-toxins-17-00092" ref-type="bibr">1</xref>,<xref rid="B9-toxins-17-00092" ref-type="bibr">9</xref>], and could help explain the massive deaths of several marine species associated with the participation of harmful algal bloom events (HABs) involving the species <italic toggle="yes">K. selliformis</italic> along the Chilean coasts [<xref rid="B9-toxins-17-00092" ref-type="bibr">9</xref>].</p><p>Regarding its neurotoxic effect, we evaluate the presence of toxins capable of activating voltage-gated sodium channels (VGSCs) (similar to compounds like brevetoxin) or with sodium-channel-blocking activity (such as saxitoxin or tetrodotoxin) using the Neuro2a CBA model. As shown in <xref rid="toxins-17-00092-f002" ref-type="fig">Figure 2</xref>, Neuro-2a cells exposed to ExKs for 24 h exhibited a potentiating cytotoxic effect of veratridine and ouabain, consistent with the effect suggested for O/V-activating type toxins. Co-incubation with 100 nM saxitoxin resulted in a reduction in toxicity observed in the presence of ouabain/veratridine. These results indicate that VGSC blockage by STX interferes with the exacerbated toxicity of activating-type toxins previously observed with the ExKs extract. Since ExKs potentiates the toxicity of veratridine in the CBA model, which is expected for sodium-channel-activating toxins like brevetoxins, this implies that ExKs could be an agonist of the effect induced by ouabain/veratridine. Our results showed that neurons treated with ExKs demonstrated a significant increase in global synaptic activity, which was silenced by the addition of TTX (<xref rid="toxins-17-00092-f003" ref-type="fig">Figure 3</xref>A). Additionally, the increase in the amplitude of synaptic events and the persistent increase in the number of neurons with larger AP-amplitudes, which were subsequently blocked by a tetrodotoxin (TTX) pulse in ExKs-treated neurons (<xref rid="toxins-17-00092-f004" ref-type="fig">Figure 4</xref>A), suggest a positive modulation of neuronal activity. This heightened excitability may have potential implications for synaptic failures and the nuanced regulation of critical neural network functionality.</p><p>The alteration in cytosolic Ca<sup>2</sup>&#x0207a; levels in hippocampal neurons when exposed to ExKs (<xref rid="toxins-17-00092-f005" ref-type="fig">Figure 5</xref>) has been observed in rat cerebellar granule neuron (CGN) cultures [<xref rid="B18-toxins-17-00092" ref-type="bibr">18</xref>] and mouse cerebrocortical neurons [<xref rid="B19-toxins-17-00092" ref-type="bibr">19</xref>] in response to exposure to VGSC-activating toxins such as PbTx-2. Calcium channels are crucial for synaptic vesicle exocytosis, and any interference at this level can lead to synaptic dysfunction, supporting the idea that ExKs may contribute to excitotoxicity and neural damage by potentiating calcium dyshomeostasis and altering neurotransmitter release, as seen in the significant reduction in SV2 immunoreactivity (<xref rid="toxins-17-00092-f006" ref-type="fig">Figure 6</xref>B). The observed potentiation in excitatory synaptic transmission suggests that the exudate extract enhances the acute efficiency of synaptic signaling, inducing a massive synaptic depletion (<xref rid="toxins-17-00092-f006" ref-type="fig">Figure 6</xref>), which could result in strong excitotoxicity and subsequent synaptic failure. This phenomenon draws intriguing parallels with other neurotoxic contexts, where enhanced neurotransmission may act as a precursor to neurodegeneration [<xref rid="B20-toxins-17-00092" ref-type="bibr">20</xref>].</p></sec><sec sec-type="conclusions" id="sec4-toxins-17-00092"><title>4. Conclusions</title><p>The data presented here shed light on several critical aspects of how <italic toggle="yes">K. selliformis</italic> exudate affects neuronal function. This study provides the first compelling evidence that exudates of this species exhibit significant neurotoxic effects mediated by potentiation of excitatory neural tone. The cell mortality was shown to increase in the presence of ExKs, from low concentrations and eliciting the maximal toxicity since the 1.25 &#x000b5;g/mL. Electrophysiological measures further confirm that these extracts disrupt the activity of electrically active mammalian cell membranes, exacerbating the impact of known excitatory toxins.</p><p>These results suggest the probable presence of novel neurotoxic compounds in <italic toggle="yes">Karenia</italic> exudates, warranting further investigation to identify and chemically characterize the compound, as well as to assess its impact on farmed fish.</p></sec><sec id="sec5-toxins-17-00092"><title>5. Materials and Methods</title><sec id="sec5dot1-toxins-17-00092"><title>5.1. Microalga Cultivation</title><p>The strain of the toxic dinoflagellate <italic toggle="yes">Karenia selliformis</italic> (CREAN-KS02), isolated from the Chilean Aysen Region at 43&#x000b0; S, was obtained from the Collection of Harmful Algae hosted at the Center for Harmful Algae Studies at the Chilean Institute for Fishery Development (CREAN/IFOP) and subsequently maintained in the Laboratory of Marine Biotoxins of the University of Concepci&#x000f3;n (LBTx-UdeC). The strain was grown in L1 medium prepared with seawater from the Chilean coast (36&#x000b0;31&#x02032; S, 73&#x000b0;08&#x02032; W), 0.2 &#x000b5;m filtered, and autoclaved, with the salinity previously adjusted to 32 PSU (salinity for which blooms of <italic toggle="yes">K. selliformis</italic> have been observed in the field [<xref rid="B1-toxins-17-00092" ref-type="bibr">1</xref>]. Cultures were maintained at 17 &#x000b0;C under 140 &#x003bc;mol photon m<sup>&#x02212;2</sup> s<sup>&#x02212;1</sup> and 16 h/8 h light/dark photoperiod.</p><p><italic toggle="yes">K. selliformis</italic> growth curves were determined from 1-L cultures initiated at 3000 cells mL<sup>&#x02212;1</sup>, inoculated from stock cultures in the exponential phase. Cell density was evaluated daily using Sedgewick Rafter chambers [<xref rid="B21-toxins-17-00092" ref-type="bibr">21</xref>]. The maximum growth rate (divisions per day) was estimated during the exponential growth phase (Stein, 1973) and was determined according to the following equation:<disp-formula id="FD1-toxins-17-00092"><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mi>&#x003bc;</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#x000d7;</mml:mo><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math></disp-formula>
where <italic toggle="yes">&#x000b5;</italic><sup>&#x02212;1</sup> is the growth rate, <italic toggle="yes">N</italic><sub>1</sub> is the initial cell concentration, <italic toggle="yes">N</italic><sub>2</sub> is the final cell concentration, <italic toggle="yes">t</italic><sub>1</sub> is the initial time, and <italic toggle="yes">t</italic><sub>2</sub> is the final time.</p></sec><sec id="sec5dot2-toxins-17-00092"><title>5.2. Extraction of Extracellular Bioactive Compounds from K. selliformis Exudates</title><p>Exudates of 1 L of <italic toggle="yes">K. selliformis</italic> culture in exponencial phase with a density of 20,000 cells mL<sup>&#x02212;1</sup> were collected by gentle vacuum filtration 400 mbar of cultures through glass fiber filters (0.7 &#x000b5;m nominal, grade F, Sterlitech) verifying under the microscope that the cells remain intact. In total, 10 g of adsorbent (diaion HP20 resin, Sigma-Aldrich, St. Louis, MI, USA) was used for extraction of the active compounds from the filtrate. Prior to application, the adsorbent was activated by gentle stirring in methanol overnight, followed by washing three times with distilled water. The activated adsorbent was added to the <italic toggle="yes">K. selliformis</italic> filtrate and was then incubated for 24 h with shaking (80 rpm) at room temperature. After incubation, the adsorbent was placed in a glass column with a fiberglass stopper. The filtrate was removed, and the column was washed with two column volumes of distilled water for the removal of salts. The elution was carried out with seven column volumes of methanol, the eluate that contained lipophilic compounds exuded by <italic toggle="yes">Karenia selliformis</italic> was collected, concentrated in a rotary evaporator at 40 &#x000b0;C, then dried at 40 &#x000b0;C in a nitrogen flow, weighed and dissolved in methanol.</p><p>This is referred to as bioactive lipophilic extract obtained from the exudate of <italic toggle="yes">K. selliformis</italic> cultures &#x0201c;ExKs&#x0201d;. As a negative control, the procedure described above was carried out with the culture medium.</p></sec><sec id="sec5dot3-toxins-17-00092"><title>5.3. Neuroblastoma Neuro-2a Cell Bioassay</title><p>The cell bioassay (CBA) was performed using the Neuroblastoma Neuro-2a cell following a protocol modified from [<xref rid="B14-toxins-17-00092" ref-type="bibr">14</xref>]. The Neuro-2a cell line was obtained from the American Type Culture Collection (ATCC, CCL 131). Cells were maintained in RPMI-1640 medium supplemented with 1 mM sodium pyruvate, 2.5 &#x003bc;g mL<sup>&#x02212;1</sup> amphotericin B, 50 IU mL<sup>&#x02212;1</sup> penicillin, 50 &#x003bc;g mL<sup>&#x02212;1</sup> streptomycin, 2 mM glutamine and 5% fetal bovine serum, and stored at 37 &#x000b0;C in a humidified 5% CO<sub>2</sub> atmosphere. Twenty-four hours prior to the assays, Neuro-2a cells were seeded in 96-well plates at 125,000 cells mL<sup>&#x02212;1</sup> in RPMI-1640 medium supplemented with (5%) fetal bovine serum and incubated under the same conditions described for cell maintenance.</p><p>For viability assays and IC<sub>50</sub> determination, Neuro-2a cells were incubated for 24 h with eight concentrations of extracts ranging from 0, 0.3, 0.6, 1.25, 1.5, 1.75, 2.0, 2.5 and 5 &#x000b5;g mL<sup>&#x02212;1</sup>. The methanol solvent content in each solution was less than 0.1% to avoid affecting the viability and functionality of the neuronal lineage.</p><p>A Neuro-2a cytotoxicity bioassay was performed to detect the presence of neurotoxins acting on VGSC. For the Neuro-2a CBA assay, cells were exposed to the extract along with ouabain/veratridine (150 &#x000b5;M/15 &#x000b5;M) to assess sodium-channel-activating toxins, or ouabain/veratridineO/V (300 &#x000b5;M/30 &#x000b5;M) to evaluate blocking toxins, in a final volume of 130 &#x003bc;L.</p><p>For both assays control Neuro-2a cells without extract were used. Additionally, to evaluate the competition of the ExKs with VGSC-blocking toxins, Neuro-2a cells were exposed to 150 &#x000b5;M ouabain, 15 &#x000b5;M, a range of concentrations from 0 to 5 &#x000b5;g mL<sup>&#x02212;1</sup> of ExKs and 100 nM of saxitoxin (National Research Council C&#x000e1;nada, Ottawa, Ontario, Canad&#x000e1;, CRM-STX-f).</p><p>After exposure, cell viability was assessed by using MTT (3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide; Life Technologies, Carlsbad, CA, USA). The cells were incubated with 60 &#x003bc;L of RPMI-1640 medium (5% FBS) containing 0.83 mg mL<sup>&#x02212;1</sup> MTT for 30 min at 37 &#x000b0;C. Formazan salts were dissolved with 100 &#x003bc;L of dimethylsulfoxide, and absorbance was measured through spectrophotometry at 570 nm using a Synergy H1 Microplate Reader (Biotek, Winooski, VT, USA).</p></sec><sec id="sec5dot4-toxins-17-00092"><title>5.4. Primary Hippocampal Cultures</title><p>Primary cultures of embryonic hippocampi (E18) were obtained from pregnant C57BL/J6 mice treated in accordance with the regulations recommended by NIH (National Institute of Health, Bethesda, MD, USA) and the ethics committee at the University of Concepci&#x000f3;n. Mice were deeply anesthetized by CO<sub>2</sub> inhalation before being sacrificed by cervical dislocation. Primary cultures of embryonic hippocampal were prepared as previously published [<xref rid="B22-toxins-17-00092" ref-type="bibr">22</xref>] and plated at 320,000 cells mL<sup>&#x02212;1</sup> on coverslips coated with poly-L-lysine (Trevigen, Gaithersburg, MD, USA). Cultures were maintained at 37 &#x000b0;C with 5% CO<sub>2</sub> for all experiments.</p></sec><sec id="sec5dot5-toxins-17-00092"><title>5.5. Electrophysiology</title><p>The whole-cell patch clamp technique was used as previously reported [<xref rid="B22-toxins-17-00092" ref-type="bibr">22</xref>,<xref rid="B23-toxins-17-00092" ref-type="bibr">23</xref>], using an Axopatch 200B amplifier (Axon Instruments, Union City, CA, USA) in voltage-clamp mode of &#x02212;60 mV. Miniature post-synaptic currents (mEPSC) were pharmacologically isolated using appropriate concentrations of TTX (50 nM) (Alomone Labs, Jerusal&#x000e9;n, Israel) and bicuculline (5 &#x003bc;M). TTX was purchased from Alomone Labs (Jerusalem, Israel) and bicuculline was from Tocris (Bristol, UK). The pipette solution was (in mM) 120 KCl, 4 MgCl<sub>2</sub>, 10 HEPES, 2 ATP, 0.5 GTP, and 10 BAPTA (pH 7.4, 300 mOsm). The bath solution contained (in mM) 150 NaCl, 5.4 KCl, 2 CaCl<sub>2</sub> 2,1 MgCl<sub>2</sub>, 10 HEPES and 10 Glucose (pH 7.4, 320 mOsm). Analysis was performed offline using Clampfit 10 (Axon Instruments, Union City, CA, USA).</p><p>To maintain a net electric current equal to zero for the &#x0201c;voltage clamp&#x0201d; mode, an external solution of fixed composition (in mM: NaCl 150; KCl 5.4; CaCl<sub>2</sub> 2; MgCl<sub>2</sub> 1; Glucose 10; HEPES 10; pH 7.4; osmolarity 300 mOsm) is used, while patch microelectrodes are filled with an internal solution of defined composition in mM: KCl 120; MgCl<sub>2</sub> 4; HEPES 10; ATP 2; GTP 0.5; pH 7.4; osmolarity 300 mOsm. For the &#x0201c;current clamp&#x0201d; mode, the external and internal solutions were prepared with different ion concentrations to simulate normal physiological conditions. Patch microelectrodes were filled with an internal solution of defined composition in mM: 114 K-Gluconate, 4 KCl, 4 MgCl<sub>2</sub>, 10 BAPTA, and 10 HEPES (pH 7.4 adjusted with KOH, 290 mOsm L<sup>&#x02212;1</sup>) for the &#x0201c;current clamp&#x0201d; mode, and they have an approximate resistance of 4&#x02013;6 M&#x003a9;. To study the membrane potential (Vm), action potentials (APs) were elicited using a series of continuous current pulses applied for 300 ms (from &#x02212;300 pA to +275 pA, increasing in steps of 25 pA).</p></sec><sec id="sec5dot6-toxins-17-00092"><title>5.6. Ca<sup>2+</sup> Measurements</title><p>Hippocampal neurons plated in bottom transparent 96-well black plates and loaded with the non-ratiometric cytosolic and mitochondrial Ca<sup>2+</sup> sensitive fluorescent probe Fluo4-AM 3 &#x003bc;M (Invitrogen, Carlsbad, CA, USA) for 30 min at 37 &#x000b0;C in PBS, using standard incubation conditions. Subsequently, the cells were washed for 20 min with PBS pH 7.4, washed 3 times with normal external solution, and finally mounted on a Nikon TE-200-U inverted microscope (Tokyo, Japan). Wavelengths of excitation and emission were 494/506 nm (Fluo-4 AM). ExKs-induced responses were expressed as a percentage of the fluorescence value at each time point (% Ft). This was calculated by subtracting the fluorescence at a given time (Ft) from the basal fluorescence value before (F0) and dividing by the F<sub>max</sub> F<sub>min</sub> fluorescence. The maximum % fluorescence intensity for Fluo-4 (maximum %[Ca<sup>2+</sup>]c) was obtained for each experiment.</p></sec><sec id="sec5dot7-toxins-17-00092"><title>5.7. Immunocytochemistry</title><p>The cells were washed with PBS 1X and fixed with 4% paraformaldehyde for 10 min at room temperature (RT). Later, cells were permeabilized with 0.1% Triton X-100 and blocked with 10% horse serum for 30 min at RT. Samples were incubated for 1 h at RT with the primary antibodies: anti-SV2 (1:200, Synaptic system, rabbit). Subsequently, the corresponding Cy3 or Alexa Fluor 488 conjugated antibodies were incubated for 45 min. Then, the samples were incubated with 300 nM DAPI nuclear staining for 10 min and mounted using DAKO immunofluorescence mounting media (Dako, Glostrup, Denmark). Images were acquired using an LSM780 NLO confocal microscope (Carl Zeiss Microscopy, Jena, Germany). The 63X/1.4 NA oil immersion objective with an additional 1.6X lens was used which explains why the total increase was 1008X. Images were processed, and quantification was performed using Image J (NIH Bethesda, Bethesda, MD, USA). To analyze SV2 puncta, we use the &#x0201c;Analyze Particles&#x0201d; tool from Image J tool, with size parameters set between 0.1 &#x000b5;m<sup>2</sup> and 3 &#x000b5;m<sup>2</sup> to capture relevant synaptic signals. Circularity was set between 0.3 to 1 to exclude artifacts. The total number of puncta per field was normalized to the area of the region of interest (ROI) as well as the number of cells manually counted in each field.</p></sec><sec id="sec5dot8-toxins-17-00092"><title>5.8. Data Analysis</title><p>The obtained data was analyzed using GraphPad Prism 6 Software. Normality was verified using the Kolmogorov&#x02013;Smirnov test or Shapiro&#x02013;Wilk normality test depending on sample size. Statistical significance was determined using unpaired Student&#x02019;s <italic toggle="yes">t</italic>-test (for two groups) or one-way ANOVA followed by Dunnett&#x02019;s multiple comparisons test (for multiple group comparisons). All experimental data were expressed as mean &#x000b1; standard error of the mean (SEM) (unless otherwise indicated). <italic toggle="yes">p</italic>-values &#x0003c; 0.05 were considered statistically significant.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors express their gratitude to their colleagues at the Harmful Algal Bloom Research Center (CREAN) of IFOP, especially for providing the CREAN_KS02 strain.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-toxins-17-00092"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/toxins17020092/s1">https://www.mdpi.com/article/10.3390/toxins17020092/s1</uri>. Figure S1: Neuro-2a cell bioassay controls.</p><supplementary-material id="toxins-17-00092-s001" position="float" content-type="local-data"><media xlink:href="toxins-17-00092-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, A.A.-G., A.A.-V., J.F. and B.K.; methodology, A.A.-G., J.P.-F., A.A.-V., J.F., N.E.-R. and B.K.; formal analysis, J.P.-F. and A.A.-G.; investigation, A.A.-V. and J.F.; data curation, A.A.-G. and J.P.-F.; writing&#x02014;original draft, A.A.-V., A.A.-G., J.P.-F. and J.F.; writing&#x02014;review and editing, A.A.-G., J.P.-F., A.A.-V., J.F., B.K., J.J.G.-R. and C.A.-d.-S.; supervision, A.A.-V. and J.F.; project administration, A.A.-V. and J.F.; funding acquisition, A.A.-V. and J.F. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was conducted in in accordance with the regulations recommended by NIH (National Institute of Health, Bethesda, MD, USA) and the ethics committee at the University of Concepci&#x000f3;n., approved under code: CEBB 667-2020, signed in May 2020.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in the article/<xref rid="app1-toxins-17-00092" ref-type="app">supplementary material</xref>. Further inquiries can be directed to the corresponding author(s).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CBA</td><td align="left" valign="middle" rowspan="1" colspan="1">Cell-based assay</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ExKs</td><td align="left" valign="middle" rowspan="1" colspan="1">The bioactive lipophilic extract derived from the exudate of <italic toggle="yes">Karenia selliformis</italic> strain (CREAN-KS02)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">STX</td><td align="left" valign="middle" rowspan="1" colspan="1">Saxitoxin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TTX</td><td align="left" valign="middle" rowspan="1" colspan="1">Tetrodoxin</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VGSC</td><td align="left" valign="middle" rowspan="1" colspan="1">voltage-gated sodium channels (VGSCs)</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-toxins-17-00092"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mardones</surname><given-names>J.I.</given-names></name>
<name><surname>Norambuena</surname><given-names>L.</given-names></name>
<name><surname>Paredes</surname><given-names>J.</given-names></name>
<name><surname>Fuenzalida</surname><given-names>G.</given-names></name>
<name><surname>Dorantes-Aranda</surname><given-names>J.J.</given-names></name>
<name><surname>Chang</surname><given-names>K.J.L.</given-names></name>
<name><surname>Guzm&#x000e1;n</surname><given-names>L.</given-names></name>
<name><surname>Krock</surname><given-names>B.</given-names></name>
<name><surname>Hallegraeff</surname><given-names>G.</given-names></name>
</person-group><article-title>Unraveling the Karenia selliformis complex with the description of a non-gymnodimine producing Patagonian phylotype</article-title><source>Harmful Algae</source><year>2020</year><volume>98</volume><fpage>101892</fpage><pub-id pub-id-type="doi">10.1016/j.hal.2020.101892</pub-id><pub-id pub-id-type="pmid">33129450</pub-id>
</element-citation></ref><ref id="B2-toxins-17-00092"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>GlobalHAB</collab>
</person-group><source>Fish-Killing Marine Algal Blooms: Causative Organisms, Ichthyotoxic Mechanisms, Impacts and Mitigation</source><person-group person-group-type="editor">
<name><surname>Hallegraeff</surname><given-names>G.M.</given-names></name>
<name><surname>Anderson</surname><given-names>D.M.</given-names></name>
<name><surname>Davidson</surname><given-names>K.</given-names></name>
<name><surname>Gianella</surname><given-names>F.</given-names></name>
<name><surname>Hansen</surname><given-names>P.J.</given-names></name>
<name><surname>Hegaret</surname><given-names>H.</given-names></name>
<name><surname>Iwataki</surname><given-names>M.</given-names></name>
<name><surname>Larsen</surname><given-names>T.O.</given-names></name>
<name><surname>Mardones</surname><given-names>J.</given-names></name>
<name><surname>MacKenzie</surname><given-names>L.</given-names></name>
<etal/>
</person-group><publisher-name>UNESCO-IOC/SCOR</publisher-name><publisher-loc>Paris, France</publisher-loc><year>2023</year></element-citation></ref><ref id="B3-toxins-17-00092"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>Q.Y.</given-names></name>
<name><surname>Chen</surname><given-names>Z.M.</given-names></name>
<name><surname>Li</surname><given-names>D.W.</given-names></name>
<name><surname>Li</surname><given-names>A.F.</given-names></name>
<name><surname>Ji</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>H.Y.</given-names></name>
<name><surname>Yang</surname><given-names>W.D.</given-names></name>
</person-group><article-title>Toxicity and potential underlying mechanism of Karenia selliformis to the fish Oryzias melastigma</article-title><source>Aquat. Toxicol.</source><year>2023</year><volume>262</volume><fpage>106643</fpage><pub-id pub-id-type="doi">10.1016/j.aquatox.2023.106643</pub-id><pub-id pub-id-type="pmid">37549486</pub-id>
</element-citation></ref><ref id="B4-toxins-17-00092"><label>4.</label><element-citation publication-type="confproc"><person-group person-group-type="author">
<name><surname>MacKenzie</surname><given-names>L.</given-names></name>
<name><surname>Rhodes</surname><given-names>L.</given-names></name>
<name><surname>Till</surname><given-names>D.</given-names></name>
<name><surname>Chang</surname><given-names>F.H.A.</given-names></name>
</person-group><article-title><italic toggle="yes">Gymnodinium</italic> sp. bloom and the contamination of shellfish with lipid soluble toxins in New Zealand. Jan-April 1993</article-title><source>Proceedings of the 6th International Conference on Toxic Marine Phytoplankton, Harmful Marine Algal Blooms, Lavoisier</source><conf-loc>Nantes, France</conf-loc><conf-date>18&#x02013;22 October 1993</conf-date><fpage>795</fpage><lpage>800</lpage></element-citation></ref><ref id="B5-toxins-17-00092"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seki</surname><given-names>T.</given-names></name>
<name><surname>Satake</surname><given-names>M.</given-names></name>
<name><surname>Mackenzie</surname><given-names>L.</given-names></name>
<name><surname>Kaspar</surname><given-names>H.F.</given-names></name>
<name><surname>Yasumoto</surname><given-names>T.</given-names></name>
</person-group><article-title>Gymnodimine, a new marine toxin of unprecedented structure isolated from New Zealand oysters and the dinoflagellate, <italic toggle="yes">Gymnodinium</italic> sp.</article-title><source>Tetrahedron Lett.</source><year>1995</year><volume>36</volume><fpage>7093</fpage><lpage>7096</lpage><pub-id pub-id-type="doi">10.1016/0040-4039(95)01434-J</pub-id></element-citation></ref><ref id="B6-toxins-17-00092"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kharrat</surname><given-names>R.</given-names></name>
<name><surname>Servent</surname><given-names>D.</given-names></name>
<name><surname>Girard</surname><given-names>E.</given-names></name>
<name><surname>Ouanounou</surname><given-names>G.</given-names></name>
<name><surname>Amar</surname><given-names>M.</given-names></name>
<name><surname>Marrouchi</surname><given-names>R.</given-names></name>
<name><surname>Benoit</surname><given-names>E.</given-names></name>
<name><surname>Molg&#x000f3;</surname><given-names>J.</given-names></name>
</person-group><article-title>The marine phycotoxin gymnodimine targets muscular and neuronal nicotinic acetylcholine receptor subtypes with high affinity</article-title><source>J. Neurochem.</source><year>2008</year><volume>107</volume><fpage>952</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05677.x</pub-id><pub-id pub-id-type="pmid">18990115</pub-id>
</element-citation></ref><ref id="B7-toxins-17-00092"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Molg&#x000f3;</surname><given-names>J.</given-names></name>
<name><surname>Marchot</surname><given-names>P.</given-names></name>
<name><surname>Ar&#x000e1;oz</surname><given-names>R.</given-names></name>
<name><surname>Benoit</surname><given-names>E.</given-names></name>
<name><surname>Iorga</surname><given-names>B.I.</given-names></name>
<name><surname>Zakarian</surname><given-names>A.</given-names></name>
<name><surname>Taylor</surname><given-names>P.</given-names></name>
<name><surname>Bourne</surname><given-names>Y.</given-names></name>
<name><surname>Servent</surname><given-names>D.</given-names></name>
</person-group><article-title>Cyclic imine toxins from dinoflagellates: A growing family of potent antagonists of the nicotinic acetylcholine receptors</article-title><source>J. Neurochem.</source><year>2017</year><volume>142</volume><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1111/jnc.13995</pub-id></element-citation></ref><ref id="B8-toxins-17-00092"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ho</surname><given-names>T.N.T.</given-names></name>
<name><surname>Abraham</surname><given-names>N.</given-names></name>
<name><surname>Lewis</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Structure-Function of Neuronal Nicotinic Acetylcholine Receptor Inhibitors Derived From Natural Toxins</article-title><source>Front. Neurosci.</source><year>2020</year><volume>14</volume><elocation-id>609005</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2020.609005</pub-id><pub-id pub-id-type="pmid">33324158</pub-id>
</element-citation></ref><ref id="B9-toxins-17-00092"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mardones</surname><given-names>J.I.</given-names></name>
</person-group><article-title>Screening of Chilean fish-killing microalgae using a gill cell-based assay</article-title><source>Lat. Am. J. Aquat. Res.</source><year>2020</year><volume>48</volume><fpage>329</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.3856/vol48-issue2-fulltext-2400</pub-id></element-citation></ref><ref id="B10-toxins-17-00092"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alfaro-Ahumada</surname><given-names>V.</given-names></name>
<name><surname>Jara-Toro</surname><given-names>S.</given-names></name>
<name><surname>Alves-de-Souza</surname><given-names>C.</given-names></name>
<name><surname>Rivera-Latorre</surname><given-names>A.</given-names></name>
<name><surname>Mardones</surname><given-names>J.I.</given-names></name>
<name><surname>Gallardo-Rodriguez</surname><given-names>J.J.</given-names></name>
<name><surname>Astuya-Villal&#x000f3;n</surname><given-names>A.</given-names></name>
</person-group><article-title>Allelopathic Effect of a Chilean Strain of <italic toggle="yes">Karenia selliformis</italic> (Gymnodiniales, Dinoflagellata) on Phytoplankton Species</article-title><source>Microorganisms</source><year>2024</year><volume>12</volume><elocation-id>1834</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms12091834</pub-id><pub-id pub-id-type="pmid">39338508</pub-id>
</element-citation></ref><ref id="B11-toxins-17-00092"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Medhioub</surname><given-names>A.</given-names></name>
<name><surname>Medhioub</surname><given-names>W.</given-names></name>
<name><surname>Amzil</surname><given-names>Z.</given-names></name>
<name><surname>Sibat</surname><given-names>M.</given-names></name>
<name><surname>Bardouil</surname><given-names>M.</given-names></name>
<name><surname>Neila</surname><given-names>I.</given-names></name>
<name><surname>Mezghani</surname><given-names>S.</given-names></name>
<name><surname>Hamza</surname><given-names>A.</given-names></name>
<name><surname>Patrick</surname><given-names>L.</given-names></name>
</person-group><article-title>Influence of environmental parameters on <italic toggle="yes">Karenia selliformis</italic> toxin content in culture</article-title><source>Cah. Biol. Mar.</source><year>2009</year><volume>50</volume><fpage>333</fpage><lpage>342</lpage></element-citation></ref><ref id="B12-toxins-17-00092"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stevens</surname><given-names>M.</given-names></name>
<name><surname>Peigneur</surname><given-names>S.</given-names></name>
<name><surname>Tytgat</surname><given-names>J.</given-names></name>
</person-group><article-title>Neurotoxins and their binding areas on voltage-gated sodium channels</article-title><source>Front. Pharmacol.</source><year>2011</year><volume>2</volume><elocation-id>71</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2011.00071</pub-id><pub-id pub-id-type="pmid">22084632</pub-id>
</element-citation></ref><ref id="B13-toxins-17-00092"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>F.</given-names></name>
<name><surname>Xu</surname><given-names>X.</given-names></name>
<name><surname>Li</surname><given-names>T.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
</person-group><article-title>Shellfish toxins targeting voltage-gated sodium channels</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>4698</fpage><lpage>4723</lpage><pub-id pub-id-type="doi">10.3390/md11124698</pub-id><pub-id pub-id-type="pmid">24287955</pub-id>
</element-citation></ref><ref id="B14-toxins-17-00092"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Manger</surname><given-names>R.L.</given-names></name>
<name><surname>Leja</surname><given-names>L.S.</given-names></name>
<name><surname>Lee</surname><given-names>S.Y.</given-names></name>
<name><surname>Hungerford</surname><given-names>J.M.</given-names></name>
<name><surname>Wekell</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Tetrazolium-Based Cell Bioassay for Neurotoxins Active on Voltage-Sensitive Sodium Channels: Semiautomated Assay for Saxitoxins, Brevetoxins, and Ciguatoxins</article-title><source>Anal. Biochem.</source><year>1993</year><volume>214</volume><fpage>190</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1006/abio.1993.1476</pub-id><pub-id pub-id-type="pmid">8250223</pub-id>
</element-citation></ref><ref id="B15-toxins-17-00092"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McCall</surname><given-names>J.R.</given-names></name>
<name><surname>Elliott</surname><given-names>E.A.</given-names></name>
<name><surname>Bourdelais</surname><given-names>A.J.</given-names></name>
</person-group><article-title>A new cytotoxicity assay for brevetoxins using fluorescence microscopy</article-title><source>Mar. Drugs</source><year>2014</year><volume>12</volume><fpage>4868</fpage><lpage>4882</lpage><pub-id pub-id-type="doi">10.3390/md12094868</pub-id><pub-id pub-id-type="pmid">25251033</pub-id>
</element-citation></ref><ref id="B16-toxins-17-00092"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vellojin</surname><given-names>J.P.</given-names></name>
<name><surname>Mardones</surname><given-names>J.I.</given-names></name>
<name><surname>Vargas</surname><given-names>V.</given-names></name>
<name><surname>Leal</surname><given-names>P.P.</given-names></name>
<name><surname>Corredor-Acosta</surname><given-names>A.</given-names></name>
<name><surname>Iriarte</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Potential effects of climate change on the growth response of the toxic dinoflagellate <italic toggle="yes">Karenia selliformis</italic> from Patagonian waters of Chile</article-title><source>Prog. Oceanogr.</source><year>2023</year><volume>211</volume><fpage>102956</fpage><pub-id pub-id-type="doi">10.1016/j.pocean.2022.102956</pub-id></element-citation></ref><ref id="B17-toxins-17-00092"><label>17.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Molg&#x000f3;</surname><given-names>J.</given-names></name>
<name><surname>Benoit</surname><given-names>E.</given-names></name>
<name><surname>Ar&#x000e1;oz</surname><given-names>R.</given-names></name>
<name><surname>Zakarian</surname><given-names>A.</given-names></name>
<name><surname>Iorga</surname><given-names>B.I.</given-names></name>
</person-group><article-title>Spirolides and Cyclic Imines: Toxicological Profile</article-title><source>Marine and Freshwater Toxins: Marine and Freshwater Toxins</source><person-group person-group-type="editor">
<name><surname>Gopalakrishnakone</surname><given-names>P.</given-names></name>
<name><surname>Haddad</surname><given-names>V.</given-names><suffix>Jr.</suffix></name>
<name><surname>Kem</surname><given-names>W.R.</given-names></name>
<name><surname>Tubaro</surname><given-names>A.</given-names></name>
<name><surname>Kim</surname><given-names>E.</given-names></name>
</person-group><publisher-name>Springer</publisher-name><publisher-loc>Dordrecht, The Netherlands</publisher-loc><year>2014</year><fpage>1</fpage><lpage>19</lpage></element-citation></ref><ref id="B18-toxins-17-00092"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>LePage</surname><given-names>K.T.</given-names></name>
<name><surname>Rainier</surname><given-names>J.D.</given-names></name>
<name><surname>Johnson</surname><given-names>H.W.B.</given-names></name>
<name><surname>Baden</surname><given-names>D.G.</given-names></name>
<name><surname>Murray</surname><given-names>T.F.</given-names></name>
</person-group><article-title>Gambierol Acts as a Functional Antagonist of Neurotoxin Site 5 on Voltage-Gated Sodium Channels in Cerebellar Granule Neurons</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2007</year><volume>323</volume><fpage>174</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1124/jpet.107.124271</pub-id><pub-id pub-id-type="pmid">17609421</pub-id>
</element-citation></ref><ref id="B19-toxins-17-00092"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>George</surname><given-names>J.</given-names></name>
<name><surname>Baden</surname><given-names>D.G.</given-names></name>
<name><surname>Gerwick</surname><given-names>W.H.</given-names></name>
<name><surname>Murray</surname><given-names>T.F.</given-names></name>
</person-group><article-title>Bidirectional influence of sodium channel activation on NMDA receptor&#x02013;dependent cerebrocortical neuron structural plasticity</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>19840</fpage><lpage>19845</lpage><pub-id pub-id-type="doi">10.1073/pnas.1212584109</pub-id><pub-id pub-id-type="pmid">23150561</pub-id>
</element-citation></ref><ref id="B20-toxins-17-00092"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>V.T.T.</given-names></name>
<name><surname>K&#x000f6;nig</surname><given-names>S.</given-names></name>
<name><surname>Eggert</surname><given-names>S.</given-names></name>
<name><surname>Endres</surname><given-names>K.</given-names></name>
<name><surname>Kins</surname><given-names>S.</given-names></name>
</person-group><article-title>The role of mycotoxins in neurodegenerative diseases: Current state of the art and future perspectives of research</article-title><source>Biol. Chem.</source><year>2022</year><volume>403</volume><fpage>3</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1515/hsz-2021-0214</pub-id><pub-id pub-id-type="pmid">34449171</pub-id>
</element-citation></ref><ref id="B21-toxins-17-00092"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malashenkov</surname><given-names>D.V.</given-names></name>
<name><surname>Dashkova</surname><given-names>V.</given-names></name>
<name><surname>Zhakupova</surname><given-names>K.</given-names></name>
<name><surname>Vorobjev</surname><given-names>I.A.</given-names></name>
<name><surname>Barteneva</surname><given-names>N.S.</given-names></name>
</person-group><article-title>Comparative analysis of freshwater phytoplankton communities in two lakes of Burabay National Park using morphological and molecular approaches</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><elocation-id>16130</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-95223-z</pub-id><pub-id pub-id-type="pmid">34373491</pub-id>
</element-citation></ref><ref id="B22-toxins-17-00092"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fuentealba</surname><given-names>J.</given-names></name>
<name><surname>Mu&#x000f1;oz</surname><given-names>B.</given-names></name>
<name><surname>Y&#x000e9;venes</surname><given-names>G.</given-names></name>
<name><surname>Moraga-Cid</surname><given-names>G.</given-names></name>
<name><surname>P&#x000e9;rez</surname><given-names>C.</given-names></name>
<name><surname>Guzm&#x000e1;n</surname><given-names>L.</given-names></name>
<name><surname>Rigo</surname><given-names>J.M.</given-names></name>
<name><surname>Aguayo</surname><given-names>L.G.</given-names></name>
</person-group><article-title>Potentiation and inhibition of glycine receptors by tutin</article-title><source>Neuropharmacology</source><year>2011</year><volume>60</volume><fpage>453</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2010.10.023</pub-id><pub-id pub-id-type="pmid">21044637</pub-id>
</element-citation></ref><ref id="B23-toxins-17-00092"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Panes-Fernandez</surname><given-names>J.</given-names></name>
<name><surname>Godoy</surname><given-names>P.A.</given-names></name>
<name><surname>Gavilan</surname><given-names>J.</given-names></name>
<name><surname>Ram&#x000ed;rez-Molina</surname><given-names>O.</given-names></name>
<name><surname>Burgos</surname><given-names>C.F.</given-names></name>
<name><surname>Marileo</surname><given-names>A.</given-names></name>
<name><surname>Flores-N&#x000fa;&#x000f1;ez</surname><given-names>O.</given-names></name>
<name><surname>Castro</surname><given-names>P.A.</given-names></name>
<name><surname>Moraga-Cid</surname><given-names>G.</given-names></name>
<name><surname>Y&#x000e9;venes</surname><given-names>G.E.</given-names></name>
<etal/>
</person-group><article-title>TG2 promotes amyloid beta aggregates: Impact on ER-mitochondria crosstalk, calcium homeostasis and synaptic function in Alzheimer&#x02019;s disease</article-title><source>Biomed. Pharmacother.</source><year>2023</year><volume>162</volume><elocation-id>114596</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2023.114596</pub-id><pub-id pub-id-type="pmid">36989728</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="toxins-17-00092-f001"><label>Figure 1</label><caption><p>Cytotoxic curve of ExKs of Karenia selliformis (CREAN_KS02) on mouse neuroblastoma cells (Neuro-2a). The cells were incubated with extract of ExKs (0&#x02013;5 &#x000b5;g mL<sup>&#x02212;1</sup>) during 24 h (black dots, R<sup>2</sup> = 0.985) or extract of culture medium (blue triangles). The calculated IC<sub>50</sub> was 2.41 &#x000b1; 0.02 &#x000b5;g mL<sup>&#x02212;1</sup>. The graph shows three experiments performed in different weeks, with three replicates each one (<italic toggle="yes">n</italic> = 3, <italic toggle="yes">N</italic> = 3).</p></caption><graphic xlink:href="toxins-17-00092-g001" position="float"/></fig><fig position="float" id="toxins-17-00092-f002"><label>Figure 2</label><caption><p>ExKs increases cytotoxicity in Neuro-2a cells in presence of ouabain (150 &#x000b5;M) and veratridine (15 &#x000b5;M). Neuro-2a cell assay for voltage-dependent sodium-channel-activating toxins exposed to ExKs, in the presence (black dot) or absence (blue triangles) of 100 nM saxitoxin. The graph shows a representative experiment of two experiments performed in different weeks, with three replicates each. (<italic toggle="yes">n</italic> = 2, <italic toggle="yes">N</italic> = 3).</p></caption><graphic xlink:href="toxins-17-00092-g002" position="float"/></fig><fig position="float" id="toxins-17-00092-f003"><label>Figure 3</label><caption><p>Karenia selliformis (CREAN_KS02) exudate extract (ExKs) induced a potentiation in the synaptic neurotransmission. (<bold>A</bold>) Illustrative scheme of perfusion for electrophysiological recordings. Representative traces of postsynaptic currents illustrate the effect of ExKs (1 &#x000b5;g mL<sup>&#x02212;1</sup>) and TTX (50 nM) applications. The graph bars show the changes in the amplitude (pA) of the recordings (left panel). The values are mean &#x000b1; SEM obtained from <italic toggle="yes">n</italic> = 8. (<bold>B</bold>) ExKs concentration&#x02013;response curve, <italic toggle="yes">n</italic> = 7. The curve describes the potentiation of the neuronal synaptic currents elicited by ExKs (right panel) (<italic toggle="yes">n</italic> = 3, <italic toggle="yes">N</italic> = 12, *** <italic toggle="yes">p</italic> &#x0003c; 0.001).</p></caption><graphic xlink:href="toxins-17-00092-g003" position="float"/></fig><fig position="float" id="toxins-17-00092-f004"><label>Figure 4</label><caption><p>Modulation of excitatory neurotransmission by Karenia selliformis (CREAN_KS02) exudate extract (ExKs). (<bold>A</bold>) Current traces showing the comparison of APs firing in control and ExKs (1 &#x003bc;g mL<sup>&#x02212;1</sup>) conditions, obtained in primary hippocampal neurons using electrophysiology patch clamp technique in current-clamp mode, and quantification of the relationship between the number of AP spikes and the injected current intensity, and the quantification of total spikes (bottom panel). The values represent mean &#x000b1; SEM, obtained from <italic toggle="yes">n</italic> = 7 hippocampal neurons. Unpaired Student&#x02019;s <italic toggle="yes">t</italic>-test was used for statistical analyses (<italic toggle="yes">n</italic> = 7&#x02013;8 per group). (<bold>B</bold>) Miniature excitatory postsynaptic currents (mEPSC) were isolated using bicuculline (5 &#x003bc;M), and TTX (0.3 &#x003bc;M), and glutamatergic synaptic activity before and during the application of ExKs (1 &#x003bc;g mL<sup>&#x02212;1</sup>). The bar plot summarizes the effects of ExKs on the amplitude of the frequency of mEPSC (Hz) in hippocampal neurons in vitro (bottom panel, <italic toggle="yes">n</italic> = 8). TTX (50 nM) was used as positive control (<italic toggle="yes">n</italic> = 3, <italic toggle="yes">N</italic> = 8,** <italic toggle="yes">p</italic> &#x0003c; 0.01, *** <italic toggle="yes">p</italic> &#x0003c; 0.001).</p></caption><graphic xlink:href="toxins-17-00092-g004" position="float"/></fig><fig position="float" id="toxins-17-00092-f005"><label>Figure 5</label><caption><p>Karenia selliformis (CREAN_KS02) exudate extract (ExKs) induced Ca<sup>2+</sup> influxes. (<bold>A</bold>) Representative traces of ExKs-induced (1 &#x003bc;g mL<sup>&#x02212;1</sup>) changes in intracellular Ca<sup>2+</sup> in hippocampal neurons after depolarizing stimulus of High K+ solution pulse (90 mM). (<bold>B</bold>) Quantification of areas under the curve (AUC) for each condition, <italic toggle="yes">n</italic> = 5&#x02013;6. *** <italic toggle="yes">p</italic> &#x0003c; 0.001 compared to the control group.</p></caption><graphic xlink:href="toxins-17-00092-g005" position="float"/></fig><fig position="float" id="toxins-17-00092-f006"><label>Figure 6</label><caption><p>Karenia selliformis (CREAN_KS02) exudate extract (ExKs) induced SV2 depletion. (<bold>A</bold>) Representative confocal microscopy images show SV2 (green) and DAPI (cyan) staining. Top: control condition; bottom: acute treatment with ExKs (1 &#x003bc;g mL&#x0207b;<sup>1</sup>). (<bold>B</bold>) Quantification of the number of SV2 puncta in primary processes per 20 &#x003bc;m from panel A. Number of primary processes quantified: Control (21 processes from 15 neurons); ExKs (24 processes from 17 neurons). *** <italic toggle="yes">p</italic> &#x0003c; 0.001 compared to the control group.</p></caption><graphic xlink:href="toxins-17-00092-g006" position="float"/></fig></floats-group></article>